RICHMOND, Calif., Aug. 30, 2017 /PRNewswire/ -- Sangamo
Therapeutics, Inc. (Nasdaq: SGMO) announced today that members of
the Company's senior management team are scheduled to participate
in the following healthcare investor conferences in September.
- Baird 2017 Global Healthcare Conference, New York, NY, September
6-7, 2017
Curt Herberts, Sangamo's chief business
officer, is scheduled to present at 3:45 pm
ET on Wednesday, September
6th.
- Wells Fargo 2017 Healthcare
Conference, Boston, MA,
September 6-7,
2017
Sandy Macrae,
M.B., Ch.B., Ph.D., Sangamo's chief executive officer, is scheduled
to present at 10:00 am ET on
Thursday, September
7th.
The presentations will be webcast live and may be accessed via a
link on the Sangamo Therapeutics website in the Investors and Media
section under Events and Presentations. The presentations will be
archived on the Sangamo website for two weeks after the event.
About Sangamo Therapeutics
Sangamo Therapeutics, Inc.
is focused on translating ground-breaking science into genomic
therapies that transform patients' lives using the Company's
industry leading platform technologies in genome editing, gene
therapy, gene regulation and cell therapy. For more information
about Sangamo, visit www.sangamo.com.
View original content with
multimedia:http://www.prnewswire.com/news-releases/sangamo-therapeutics-announces-presentations-at-upcoming-investor-conferences-300511623.html
SOURCE Sangamo Therapeutics, Inc.